Why this practice exists

The gap this practice sits in

Count the products aimed at someone who already trades. Signal subscriptions. Courses. Mentorships. Prop firm challenges. Indicator packs. Copy-trading rooms. Rebate portals. Every one of them sells an addition, and every one is paid whether or not the buyer’s account survives contact with it.

Almost nobody sells a verdict on what the trader is already doing. The reason is commercial rather than mysterious. A meaningful share of honest verdicts would read: this method shows no measurable edge over the sample provided, and adding capital will accelerate the losses rather than fix them. That sentence does not renew a subscription. It also happens to be the most valuable thing many traders could be told in their first two years.

What the work actually is

We take the record a trader already has and read it properly. Fills, sizing, costs, timing, holding periods, and the behaviour that shows up between the lines of a trade log once it is sorted by something other than date.

The closest analogue is not anything sold to retail. It is the risk function inside a fund. A risk desk does not tell a portfolio manager what to buy. It tells him what his own book is doing, where the exposure concentrates, and which of his assumptions the data has quietly stopped supporting. That function exists at every serious institution and almost nowhere in retail, which is odd, because the retail trader is the one with no colleagues to argue with.

Output is a written document. Not a call, not a dashboard, not a subscription, not a course. Documents can be re-read six months later when the same question comes back in a different form, and they can be disagreed with in writing, which conversations cannot.

What we refuse, and what refusing costs

No managed accounts. No signals or copy trading. No introducing-broker agreements, no rebates, no revenue share from any venue. No fee linked to a client’s performance. No forecasts of any kind.

The rebate point is worth dwelling on, because it is where most independence claims in this market quietly fail. A broker will typically pay a share of the spread on every lot a referred client trades, indefinitely. Any review practice that accepts those payments has an interest in its clients continuing to trade, which is exactly the interest a review is supposed to be free of. Turning the money down is not a moral posture. It is the only structure under which a report can conclude that a method should stop.

How to check this before paying anything

Three things sit in the open on purpose.

The method page describes every metric and decision rule, step by step, including the thresholds at which a finding is withheld for want of data. Publishing it invites copying. Copying it is fine. The method is easy to describe and slow to execute well, which is true of most analytical work.

The sample report is complete and ungated. Read it before deciding whether the reasoning is worth money.

The blog is the same method applied to problems nobody has paid us to solve. It runs roughly twice a month and contains no calls, no positions and no promotion.

On the size and standing of this practice

[ PLACEHOLDER. Replace before publishing: legal structure, jurisdiction, year the practice began, and the names and professional background of the people who sign reviews. Nothing invented has been written into this section. ]

Two things will not appear on this page in the meantime. A licence we do not hold, and a client count nobody outside this office could verify. A review practice that inflates its own record has already answered the only question a reader needs to ask about it.

The work is analytical, not regulated advisory work, and it is described that way throughout the site for a reason: the distinction is what keeps a diagnostic report from becoming a personal recommendation.